Heamonetics

Forecast & Rating11 analysts currently cover Heamonetics, with about 81.8% giving a positive rating — meaning they expect the stock to rise. The average price target is $122.20, about 0.1% upside from the current price of $122.06. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 45.8% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Heamonetics closely still see room for the stock to rise. Data as of Oct 12, 2026; for reference only and not investment advice.